Outset Medical (OM) said Monday it signed a securities purchase agreement for a placement of 843,908 shares of its series A non-voting convertible preferred stock at $200 per share, for expected gross proceeds of $168.8 million.
Each share of the preferred stock will convert to 250 shares of common stock for a total of about 211 million shares, the company said. An additional $3.9 million will be invested by some members of its board and management, the company said.
Outset also said it has signed a credit agreement with a fund managed by Perceptive Advisors, which will provide a $100 million five-year term loan and an additional term loan of up to $25 million at the company's election.
Outset also reported unaudited revenue for Q4 of $29 million.
Analysts polled by FactSet expected $27.9 million.
Price: 1.48, Change: +0.08, Percent Change: +5.36
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.